Glenna Mileson - Apr 12, 2022 Form 4 Insider Report for Athira Pharma, Inc. (ATHA)

Role
Chief Financial Officer
Signature
/s/ Glenna Mileson
Stock symbol
ATHA
Transactions as of
Apr 12, 2022
Transactions value $
$31,920
Form type
4
Date filed
4/12/2022, 07:36 PM
Previous filing
Jan 20, 2022
Next filing
Jun 24, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATHA Common Stock Options Exercise $31.9K +3K +3.09% $10.64 100K Apr 11, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATHA Stock Option (right to buy) Options Exercise $0 -3K -1.76% $0.00 167K Apr 11, 2022 Common Stock 3K $10.64 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One forty-eighth (1/48th) of the shares subject to the option will vest on February 18, 2022, and one forty-eighth of the shares subject to the option will vest each month thereafter.